StephenTillesMD
Allergy & Immunology • Seattle, WAAsthma & Allergic Conditions
Partner, Northwest Asthma and Allergy Center; Executive Director,ASTHMA Inc. Clinical research Center
Dr. Tilles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St.
Seattle, WA 98195Phone+1 206-598-4615
Education & Training
University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 1993 - 1995
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1990 - 1993
University of California San Diego School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1992 - Present
OR State Medical License 1991 - Present
WA State Medical License 2000 - 2027
CO State Medical License 1994 - 1995
American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. Start of enrollment: 2002 Sep 01
- Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma Start of enrollment: 2012 Oct 01
- Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy Start of enrollment: 2015 Mar 03
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsHLA-DRregulatory T cells and IL-10 are associated with success or failure of desensitization outcomes.Xiaoying Zhou, Diane Dunham, Sayantani B Sindher, Andrew Long, Andrea Fernandes
Allergy. 2025-03-01 - Real-world safety experience with Peanut (Arachis hypogaea) Allergen Powder-dnfp in 2500 children with peanut allergy.Michele Jara, Ekaterina Walker, Stephen Tilles, Aikaterini Anagnostou
Annals of Allergy, Asthma & Immunology. 2024-06-01 - 8 citationsPreparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent.Douglas P Mack, Timothy E Dribin, Paul J Turner, Richard L Wasserman, Mariam A Hanna
The Journal of Allergy and Clinical Immunology. 2024-06-01
Journal Articles
- Foreword Drug Hypersensitivity: Broadening HorizonsStephen Tilles, MD, ScienceDirect
Press Mentions
Are Sunflower Seed Allergies Actually Increasing in Kids?March 3rd, 2025- FDA Approves Palforzia: Breakthrough Peanut Allergy Treatment for Toddlers Offers New Hope to FamiliesMarch 1st, 2025
- Palforzia® Oral Immunotherapy for the Treatment of Peanut Allergy Now Available in the U.S. For Pediatric Ages 1 Through 3 YearsFebruary 28th, 2025
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
